| Breakdown | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 66.72B | 61.90B | 59.06B | 59.63B | 57.67B |
| Gross Profit | 40.97B | 36.25B | 30.36B | 35.02B | 34.41B |
| EBITDA | 46.34B | 42.60B | 40.21B | 39.98B | 40.20B |
| Net Income | 28.19B | 20.43B | 22.35B | 22.73B | 22.72B |
Balance Sheet | |||||
| Total Assets | 948.10B | 963.49B | 958.75B | 963.57B | 900.31B |
| Cash, Cash Equivalents and Short-Term Investments | 31.77B | 26.72B | 54.88B | 50.03B | 47.32B |
| Total Debt | 410.95B | 420.55B | 407.55B | 407.55B | 378.56B |
| Total Liabilities | 443.15B | 454.12B | 440.57B | 441.75B | 410.84B |
| Stockholders Equity | 504.94B | 509.37B | 518.17B | 521.82B | 489.47B |
Cash Flow | |||||
| Free Cash Flow | 47.15B | 7.97B | 31.09B | -36.91B | 30.70B |
| Operating Cash Flow | 54.95B | 50.21B | 37.39B | 41.61B | 44.18B |
| Investing Cash Flow | -8.14B | -41.99B | -6.40B | -76.99B | -13.43B |
| Financing Cash Flow | -42.25B | -16.33B | -26.14B | 38.08B | -22.81B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥603.80B | 21.68 | ― | 4.28% | 27.21% | 39.13% | |
73 Outperform | $405.00B | 20.82 | 6.92% | 5.16% | -27.01% | 18.03% | |
72 Outperform | ¥431.54B | 21.36 | 7.12% | 3.74% | 78.62% | 28.76% | |
70 Neutral | ¥686.66B | 20.34 | 5.51% | 4.64% | 24.10% | -30.38% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
63 Neutral | ¥593.28B | 23.54 | 6.80% | 4.46% | 52.74% | 14.88% |